197
Views
0
CrossRef citations to date
0
Altmetric
Reviews

Antiinflammatory Activities of Curcumin and Spirulina: Focus on Their Role against COVID-19

, , , , , , , & show all

References

  • Abd El-Baky HH, El-Baroty GS. Spirulina maxima L-asparaginase: immobilization, antiviral and antiproliferation activities. Recent Pat Biotechnol. 2020;14(2):154–163. doi:10.2174/1872208313666191114151344.
  • Acharya S, Momin A, Gajjar A. Review of piperine as a bio-enhancer. Am J Pharm Tech Res. 2012;2:32–44.
  • Ali SK, Saleh AM. Spirulina-an overview. 2012.
  • Alvarenga L, Salarolli R, Cardozo LFMF, Santos RS, de Brito JS, Kemp JA, Reis D, de Paiva BR, Stenvinkel P, Lindholm B, et al. Impact of curcumin supplementation on expression of inflammatory transcription factors in hemodialysis patients: a pilot randomized, double-blind, controlled study. Clin Nutr. 2020;39(12):3594–3600. doi:10.1016/j.clnu.2020.03.007.
  • Ambegaokar SS, Wu L, Alamshahi K, Lau J, Jazayeri L, Chan S, Khanna P, Hsieh E, Timiras PS. Curcumin inhibits dose-dependently and time-dependently neuroglial cell proliferation and growth. Neuro Endocrinol Lett. 2003;24(6):469–473.
  • Anvar A, Nowruzi B. Bioactive properties of spirulina: a review. Microbial Bioactives. 2021;4:134–142. doi:10.25163/microbbioacts.412117B0719110521.
  • Asadirad A, Nashibi R, Khodadadi A, Ghadiri AA, Sadeghi M, Aminian A, Dehnavi S. Antiinflammatory potential of nano-curcumin as an alternative therapeutic agent for the treatment of mild-to-moderate hospitalized COVID-19 patients in a placebo-controlled clinical trial. Phytother Res. 2022;36(2):1023–1031. doi:10.1002/ptr.7375.
  • Askari G, Alikiaii B, Soleimani D, Sahebkar A, Mirjalili M, Feizi A, Iraj B, Bagherniya M. Effect of curcumin-pipeine supplementation on clinical status, mortality rate, oxidative stress, and inflammatory markers in critically ill ICU patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial. Trials. 2021;22(1):434.
  • Babaeekhou L, Ghane M, Abbas-Mohammadi M. In silico targeting SARS-CoV-2 spike protein and main protease by biochemical compounds. Biologia (Bratisl). 2021;76(11):3547–3565. doi:10.1007/s11756-021-00881-z.
  • Barnett JB, Dao MC, Hamer DH, Kandel R, Brandeis G, Wu D, Dallal GE, Jacques PF, Schreiber R, Kong E, et al. Effect of zinc supplementation on serum zinc concentration and T cell proliferation in nursing home elderly: a randomized, double-blind, placebo-controlled trial. Am J Clin Nutr. 2016;103(3):942–951. doi:10.3945/ajcn.115.115188.
  • Beck MA, Handy J, Levander OA. The role of oxidative stress in viral infections. Ann N Y Acad Sci. 2000;917(1):906–912. doi:10.1111/j.1749-6632.2000.tb05456.x.
  • Biller-Takahashi JD, Takahashi LS, Mingatto FE, Urbinati EC. The immune system is limited by oxidative stress: dietary selenium promotes optimal antioxidative status and greatest immune defense in pacu Piaractus mesopotamicus. Fish Shellfish Immunol. 2015;47(1):360–367. doi:10.1016/j.fsi.2015.09.022.
  • Bormann M, et al. Turmeric root and its bioactive ingredient curcumin effectively neutralize SARS-CoV-2 in vitro. 2021;13(10):1914.
  • Bose S, Panda AK, Mukherjee S, Sa G. Curcumin and tumor immune-editing: resurrecting the immune system. Cell Div. 2015;10:6.
  • Chabot AB, Huntwork MP. Turmeric as a possible treatment for COVID-19-induced anosmia and ageusia. Cureus. 2021;13(9):e17829. doi:10.7759/cureus.17829.
  • Chei S, Oh H-J, Song J-H, Seo Y-J, Lee K, Kim K-J, Lee B-Y. Spirulina maxima extract prevents activation of the NLRP3 inflammasome by inhibiting ERK signaling. Sci Rep. 2020;10(1):2075. doi:10.1038/s41598-020-58896-6.
  • Chen D-Y, Shien J-H, Tiley L, Chiou S-S, Wang S-Y, Chang T-J, Lee Y-J, Chan K-W, Hsu W-L. Curcumin inhibits influenza virus infection and haemagglutination activity. Food Chem. 2010;119(4):1346–1351. doi:10.1016/j.foodchem.2009.09.011.
  • Chen M-H, Lee M-Y, Chuang J-J, Li Y-Z, Ning S-T, Chen J-C, Liu Y-W. Curcumin inhibits HCV replication by induction of heme oxygenase-1 and suppression of AKT. Int J Mol Med. 2012;30(5):1021–1028. doi:10.3892/ijmm.2012.1096.
  • Chopra AS, Lordan R, Horbańczuk OK, Atanasov AG, Chopra I, Horbańczuk JO, Jóźwik A, Huang L, Pirgozliev V, Banach M, et al. The current use and evolving landscape of nutraceuticals. Pharmacol Res. 2022;175:106001.
  • Colpitts CC, Schang LM, Rachmawati H, Frentzen A, Pfaender S, Behrendt P, Brown RJP, Bankwitz D, Steinmann J, Ott M, et al. Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells. Gut. 2014;63(7):1137–1149. doi:10.1136/gutjnl-2012-304299.
  • Costagliola G, Nuzzi G, Spada E, Comberiati P, Verduci E, Peroni DG. Nutraceuticals in viral infections: an overview of the immunomodulating properties. Nutrients. 2021;13(7):2410. doi:10.3390/nu13072410.
  • Deng R, Chow TJ. Hypolipidemic, antioxidant, and antiinflammatory activities of microalgae Spirulina. Cardiovasc Ther. 2010;28(4):e33–45. doi:10.1111/j.1755-5922.2010.00200.x.
  • Derosa G, Maffioli P, D’Angelo A, Di Pierro F. Nutraceutical approach to preventing coronavirus disease 2019 and related complications. Front Immunol. 2021;12:582556. doi:10.3389/fimmu.2021.582556.
  • DiNicolantonio JJ. A nutraceutical strategy for downregulating TGFβ signalling: prospects for prevention of fibrotic disorders, including post-COVID-19 pulmonary fibrosis. Open Heart. 2021;8(1).
  • Esposito T, Lucariello A, Hay E, Contieri M, Tammaro P, Varriale B, Guerra G, De Luca A, Perna A. Effects of curcumin and its adjuvant on TPC1 thyroid cell line. Chem Biol Interact. 2019;305:112–118. doi:10.1016/j.cbi.2019.03.031.
  • Gao S. Bio-Inspired Computational Algorithms and Their Applications. 2012: BoD–Books on Demand. InTech.
  • Goc A, Niedzwiecki A, Ivanov V, Ivanova S, Rath M. Inhibitory effects of specific combination of natural compounds against SARS-CoV-2 and its Alpha, Beta, Gamma, Delta, Kappa, and Mu variants. Eur J Microbiol Immunol. 2022;11(4):87–94. doi:10.1556/1886.2021.00022.
  • Goc A, Sumera W, Rath M, Niedzwiecki A. Phenolic compounds disrupt spike-mediated receptor-binding and entry of SARS-CoV-2 pseudo-virions. PLoS One. 2021;16(6):e0253489. doi:10.1371/journal.pone.0253489.
  • Gombart AF, Pierre A, Maggini S. A review of micronutrients and the immune system-working in harmony to reduce the risk of infection. nutrients. 2020;12(1):236. doi:10.3390/nu12010236.
  • Gómez-Téllez A, Sierra-Puente D, Muñoz-Gómez R, Ibarra-Pitts A, Guevara-Cruz M, Hernández-Ortega M, Gutiérrez-Salmeán G. Effects of a low-dose spirulina/turmeric supplement on cardiometabolic and antioxidant serum markers of patients with abdominal obesity. Front Nutr. 2020;7:65.
  • Guijarro-Real C, Plazas M. Potential in vitro inhibition of selected plant extracts against SARS-CoV-2 chymotripsin-like protease (3CL(Pro). Activity. 2021;10(7):1503.
  • Halder P, Pal U, Paladhi P, Dutta S, Paul P, Pal S, Das D, Ganguly A, Dutta I, Mandal S, et al. Evaluation of potency of the selected bioactive molecules from Indian medicinal plants with M(Pro) of SARS-CoV-2 through in silico analysis. J Ayurveda Integr Med. 2022;13(2):100449. doi:10.1016/j.jaim.2021.05.003.
  • Haq I-U, Imran M, Nadeem M, Tufail T, Gondal TA, Mubarak MS. Piperine: a review of its biological effects. Phytother Res. 2021;35(2):680–700. doi:10.1002/ptr.6855.
  • Hassaniazad M, Eftekhar E, Inchehsablagh BR, Kamali H, Tousi A, Jaafari MR, Rafat M, Fathalipour M, Nikoofal-Sahlabadi S, Gouklani H, et al. A triple-blind, placebo-controlled, randomized clinical trial to evaluate the effect of curcumin-containing nanomicelles on cellular immune responses subtypes and clinical outcome in COVID-19 patients. Phytother Res. 2021;35(11):6417–6427. doi:10.1002/ptr.7294.
  • Hatamipour M, Sahebkar A, Alavizadeh SH, Dorri M, Jaafari MR. Novel nanomicelle formulation to enhance bioavailability and stability of curcuminoids. Iran J Basic Med Sci. 2019;22(3):282–289.
  • Hay E, Lucariello A, Contieri M, Esposito T, De Luca A, Guerra G, Perna A. Therapeutic effects of turmeric in several diseases: an overview. Chem Biol Interact. 2019;310:108729.
  • Hernández-Corona A, Nieves I, Meckes M, Chamorro G, Barron BL. Antiviral activity of Spirulina maxima against herpes simplex virus type 2. Antiviral Res. 2002;56(3):279–285.
  • Honarkar Shafie E, Taheri F, Alijani N, Okhovvat AR, Goudarzi R, Borumandnia N, Aghaghazvini L, Rezayat SM, Jamalimoghadamsiahkali S, Hosseinzadeh-Attar MJ, et al. Effect of nanocurcumin supplementation on the severity of symptoms and length of hospital stay in patients with COVID-19: a randomized double-blind placebo-controlled trial. Phytother Res. 2022;36(2):1013–1022. doi:10.1002/ptr.7374.
  • Hu Q, Xiong Y, Zhu G-H, Zhang Y-N, Zhang Y-W, Huang P, Ge G-B. The SARS-CoV-2 main protease (Mpro): structure, function, and emerging therapies for COVID-19. MedComm (2020). 2022;3(3):e151. doi:10.1002/mco2.151.
  • Jena AB, Kanungo N, Nayak V, Chainy GBN, Dandapat J. Catechin and curcumin interact with S protein of SARS-CoV2 and ACE2 of human cell membrane: insights from computational studies. Sci Rep. 2021;11(1):2043. doi:10.1038/s41598-021-81462-7.
  • Jennings MR, Parks RJ. Curcumin as an antiviral agent. Viruses. 2020;12(11):1242. doi:10.3390/v12111242.
  • Jobin C, Bradham CA, Russo MP, Juma B, Narula AS, Brenner DA, Sartor RB. Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity. J Immunol. 1999;163(6):3474–3483. doi:10.4049/jimmunol.163.6.3474.
  • Joseph J. The use of pseudotyped coronaviruses for the screening of entry inhibitors: green tea extract inhibits the entry of SARS-CoV-1, MERS-CoV, and SARS-CoV-2 by blocking receptor-spike interaction. Curr Pharm Biotechnol. 2022;23(8):1118–1129.
  • Kaivola J, Nyman TA. Inflammasomes and SARS-CoV-2 infection. Viruses. 2021;13(12):2513.
  • Kalra EK. Nutraceutical–definition and introduction. AAPS Pharm Sci. 2003;5(3):E25. doi:10.1208/ps050325.
  • Kandeil A, Mostafa A. Bioactive polyphenolic compounds showing strong antiviral activities against severe acute respiratory syndrome coronavirus 2. Pathogens. 2021;10(6):758.
  • Karkos PD, Leong SC, Karkos CD, Sivaji N, Assimakopoulos DA. Spirulina in clinical practice: evidence-based human applications. Evid Based Complement Alternat Med 2011. 2011;2011:531053.
  • Karunaweera N, Raju R, Gyengesi E, Münch G. Plant polyphenols as inhibitors of NF-κB induced cytokine production—a potential anti-inflammatory treatment for Alzheimer’s disease? Front Mol Neurosci. 2015;8:24. doi:10.3389/fnmol.2015.00024.
  • Kelley N, et al. The NLRP3 inflammasome: an overview of mechanisms of activation and regulation. Int J Mol Sci. 2019;20(13):3328.
  • Kirtane AR, Verma M, Karandikar P, Furin J, Langer R, Traverso G. Nanotechnology approaches for global infectious diseases. Nat Nanotechnol. 2021;16(4):369–384. doi:10.1038/s41565-021-00866-8.
  • Ku CS, Pham TX, Park Y, Kim B, Shin MS, Kang I, Lee J. Edible blue-green algae reduce the production of pro-inflammatory cytokines by inhibiting NF-κB pathway in macrophages and splenocytes. Biochim Biophys Acta. 2013;1830(4):2981–2988. doi:10.1016/j.bbagen.2013.01.018.
  • Kumar M, Sodhi KK, Singh DK. Addressing the potential role of curcumin in the prevention of COVID-19 by targeting the Nsp9 replicase protein through molecular docking. Arch Microbiol. 2021;203(4):1691–1696. doi:10.1007/s00203-020-02163-9.
  • Kuzmenko YV, Smirnova OA, Ivanov AV, Starodubova ES, Karpov VL. Nonstructural protein 1 of tick-borne encephalitis virus induces oxidative stress and activates antioxidant defense by the Nrf2/ARE pathway. Intervirology. 2016;59(2):111–117. doi:10.1159/000452160.
  • Lordan R, Rando HM. Dietary supplements and nutraceuticals under investigation for COVID-19 prevention and treatment. 2021;6(3):e00122–21.
  • Maares M, Haase H. Zinc and immunity: an essential interrelation. Arch Biochem Biophys. 2016;611:58–65. doi:10.1016/j.abb.2016.03.022.
  • Mahmud S, Uddin MAR, Paul GK, Shimu MSS, Islam S, Rahman E, Islam A, Islam MS, Promi MM, Emran TB, et al. Virtual screening and molecular dynamics simulation study of plant-derived compounds to identify potential inhibitors of main protease from SARS-CoV-2. Brief Bioinform. 2021;22(2):1402–1414. doi:10.1093/bib/bbaa428.
  • Marín-Palma D, et al. Curcumin inhibits in vitro SARS-CoV-2 infection in vero E6 cells through multiple antiviral mechanisms. Molecules. 2021;26(22):6900. doi:10.3390/molecules26226900.
  • Meydani SN, Barnett JB, Dallal GE, Fine BC, Jacques PF, Leka LS, Hamer DH. Serum zinc and pneumonia in nursing home elderly. Am J Clin Nutr. 2007;86(4):1167–1173. doi:10.1093/ajcn/86.4.1167.
  • Mounce BC, Cesaro T, Carrau L, Vallet T, Vignuzzi M. Curcumin inhibits Zika and chikungunya virus infection by inhibiting cell binding. Antiviral Res. 2017;142:148–157. doi:10.1016/j.antiviral.2017.03.014.
  • Mulu A, Gajaa M, Woldekidan HB, W/Mariam JF. The impact of curcumin derived polyphenols on the structure and flexibility COVID-19 main protease binding pocket: a molecular dynamics simulation study. PeerJ. 2021;9:e11590. doi:10.7717/peerj.11590.
  • Naeini F, Zarezadeh M, Mohiti S, Tutunchi H, Ebrahimi Mamaghani M, Ostadrahimi A. Spirulina supplementation as an adjuvant therapy in enhancement of antioxidant capacity: a systematic review and meta-analysis of controlled clinical trials. Int J Clin Pract. 2021;75(10):e14618.
  • Nag A, Paul S, Banerjee R, Kundu R. In silico study of some selective phytochemicals against a hypothetical SARS-CoV-2 spike RBD using molecular docking tools. Comput Biol Med. 2021;137:104818.
  • Ngo-Matip M-E, Pieme CA, Azabji-Kenfack M, Moukette BM, Korosky E, Stefanini P, Ngogang JY, Mbofung CM. Impact of daily supplementation of Spirulina platensis on the immune system of naïve HIV-1 patients in Cameroon: a 12-months single blind, randomized, multicenter trial. Nutr J. 2015;14:70.
  • Noor H, Ikram A. Immunomodulatory and anti-cytokine therapeutic potential of curcumin and its derivatives for treating COVID-19 - a computational modeling. 2022;40(13):5769–5784.
  • Nowruzi B, Sarvari G, Blanco S. Applications of cyanobacteria in biomedicine, in Handbook of Algal Science, Technology and Medicine. 2020, Academic Press, Elsevier. p. 441–453.
  • Patel A, et al. Virtual screening of curcumin and its analogs against the spike surface glycoprotein of SARS-CoV-2 and SARS-CoV. 2022;40(11):5138–5146.
  • Pecora F, Persico F, Argentiero A, Neglia C, Esposito S. The role of micronutrients in support of the immune response against viral infections. Nutrients. 2020;12(10):3198. doi:10.3390/nu12103198.
  • Peng Y, Ao M, Dong B, Jiang Y, Yu L, Chen Z, Hu C, Xu R. Anti-inflammatory effects of curcumin in the inflammatory diseases: status, limitations and countermeasures. Drug Des Dev Ther. 2021;15:4503–4525. doi:10.2147/DDDT.S327378.
  • Peng Y, Ao M, Dong B, Jiang Y, Yu L, Chen Z, Hu C, Xu R. Anti-inflammatory effects of curcumin in the inflammatory diseases: status, limitations and countermeasures. Drug Des Devel Ther. 2021;15:4503–4525. doi:10.2147/DDDT.S327378.
  • Pentón-Rol G, Marín-Prida J, McCarty MF. C-Phycocyanin-derived phycocyanobilin as a potential nutraceutical approach for major neurodegenerative disorders and COVID-19- induced damage to the nervous system. Curr Neuropharmacol. 2021;19(12):2250–2275. doi:10.2174/1570159X19666210408123807.
  • Perna A, De Luca A, Adelfi L, Pasquale T, Varriale B, Esposito T. Effects of different extracts of curcumin on TPC1 papillary thyroid cancer cell line. BMC Complement Altern Med. 2018;18(1):63. doi:10.1186/s12906-018-2125-9.
  • Pourhajibagher M, et al. Robust antimicrobial photodynamic therapy with curcumin-poly (lactic-co-glycolic acid) nanoparticles against COVID-19: a preliminary in vitro study in Vero cell line as a model. Photodiagn Photodyn Ther. 2021;34:102286.
  • Praditya D, Kirchhoff L, Brüning J, Rachmawati H, Steinmann J, Steinmann E. Anti-infective properties of the golden spice curcumin. Front Microbiol. 2019;10:912.
  • Rattis BAC, Ramos SG, Celes MRN. Curcumin as a potential treatment for COVID-19. Front Pharmacol. 2021;12:675287. doi:10.3389/fphar.2021.675287.
  • Roshdy WH, Rashed HA, Kandeil A, Mostafa A, Moatasim Y, Kutkat O, Abo Shama NM, Gomaa MR, El-Sayed IH, El Guindy NM, et al. EGYVIR: an immunomodulatory herbal extract with potent antiviral activity against SARS-CoV-2. PLoS One. 2020;15(11):e0241739. doi:10.1371/journal.pone.0241739.
  • Rouse BT, Sehrawat S. Immunity and immunopathology to viruses: what decides the outcome? Nat Rev Immunol. 2010;10(7):514–526. doi:10.1038/nri2802.
  • Santini A, Cammarata SM, Capone G, Ianaro A, Tenore GC, Pani L, Novellino E. Nutraceuticals: opening the debate for a regulatory framework. Br J Clin Pharmacol. 2018;84(4):659–672. doi:10.1111/bcp.13496.
  • Satyaraj E, Reynolds A, Engler R, Labuda J, Sun P. Supplementation of diets with spirulina influences immune and gut function in dogs. Front Nutr. 2021;8:667072.
  • Shakibaei M, John T, Schulze-Tanzil G, Lehmann I, Mobasheri A. Suppression of NF-kappaB activation by curcumin leads to inhibition of expression of cyclo-oxygenase-2 and matrix metalloproteinase-9 in human articular chondrocytes: implications for the treatment of osteoarthritis. Biochem Pharmacol. 2007;73(9):1434–1445. doi:10.1016/j.bcp.2007.01.005.
  • Sharma VK, Singh SP, Singh BN, Rao CV, Barik, SK, Prateeksha. Nanocurcumin potently inhibits SARS-CoV-2 spike protein-induced cytokine storm by deactivation of MAPK/NF-κB signaling in epithelial cells. ACS Appl Bio Mater. 2022;5(2):483–491. doi:10.1021/acsabm.1c00874.
  • Shimizu Y. Understanding the immunopathogenesis of COVID-19: its implication for therapeutic strategy. World J Clin Cases. 2020;8(23):5835–5843. doi:10.12998/wjcc.v8.i23.5835.
  • Singh S, Aggarwal BB. Activation of transcription factor NF-κB is suppressed by curcumin (diferuloylmethane). J Biol Chem. 1995;270(42):24995–25000. doi:10.1074/jbc.270.42.24995.
  • Singh S, Kola P, Kaur D, Singla G, Mishra V, Panesar PS, Mallikarjunan K, Krishania M. Therapeutic potential of nutraceuticals and dietary supplements in the prevention of viral diseases: a review. Front Nutr. 2021;8:679312. doi:10.3389/fnut.2021.679312.
  • Singh S, Kola P, Kaur D, Singla G, Mishra V, Panesar PS, Mallikarjunan K, Krishania M. Therapeutic potential of nutraceuticals and dietary supplements in the prevention of viral diseases: a review. Front Nutr. 2021;8:679312. doi:10.3389/fnut.2021.679312.
  • Suhail S, Zajac J, Fossum C, Lowater H, McCracken C, Severson N, Laatsch B, Narkiewicz-Jodko A, Johnson B, Liebau J, et al. Role of oxidative stress on SARS-CoV (SARS) and SARS-CoV-2 (COVID-19) infection: a review. Protein J. 2020;39(6):644–656. doi:10.1007/s10930-020-09935-8.
  • Tahmasebi S, Saeed BQ, Temirgalieva E, Yumashev AV, El-Esawi MA, Navashenaq JG, Valizadeh H, Sadeghi A, Aslani S, Yousefi M, et al. Nanocurcumin improves Treg cell responses in patients with mild and severe SARS-CoV2. Life Sci. 2021;276:119437.
  • Teli DM, Shah MB, Chhabria MT. In silico screening of natural compounds as potential inhibitors of SARS-CoV-2 main protease and spike RBD: targets for COVID-19. Front Mol Biosci. 2021;7:599079. doi:10.3389/fmolb.2020.599079.
  • Tzachor A, Rozen O, Khatib S, Jensen S, Avni D. Photosynthetically controlled spirulina, but not solar spirulina, inhibits TNF-α secretion: potential implications for COVID-19-related cytokine storm therapy. Mar Biotechnol (NY). 2021;23(1):149–155. doi:10.1007/s10126-021-10020-z.
  • Umadevi P, et al. In silico analysis of phytochemicals as potential inhibitors of proteases involved in SARS-CoV-2 infection. J Biomol Struct Dyn. 2022;40(11):5053–5059.
  • Umashankar V, Deshpande SH, Hegde HV, Singh I, Chattopadhyay D. Phytochemical moieties from indian traditional medicine for targeting dual hotspots on SARS-CoV-2 spike protein: an integrative in-silico approach. Front Med. 2021;8:672629.
  • Valizadeh H, Abdolmohammadi-Vahid S, Danshina S, Ziya Gencer M, Ammari A, Sadeghi A, Roshangar L, Aslani S, Esmaeilzadeh A, Ghaebi M, et al. Nano-curcumin therapy, a promising method in modulating inflammatory cytokines in COVID-19 patients. Int Immunopharmacol. 2020;89(Pt B):107088. doi:10.1016/j.intimp.2020.107088.
  • Wen C-C, Kuo Y-H, Jan J-T, Liang P-H, Wang S-Y, Liu H-G, Lee C-K, Chang S-T, Kuo C-J, Lee S-S, et al. Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus. J Med Chem. 2007;50(17):4087–4095. doi:10.1021/jm070295s.
  • Wu Q, Liu L, Miron A, Klímová B, Wan D, Kuča K. The antioxidant, immunomodulatory, and anti-inflammatory activities of Spirulina: an overview. Arch Toxicol. 2016;90(8):1817–1840. doi:10.1007/s00204-016-1744-5.
  • Kaivola J, Nyman TA, Matikainen S. Inflammasomes and SARS-CoV-2 Infection. Viruses. 2021;13(12):2513. doi:10.3390/v13122513. PMID: 34960782; PMCID: PMC8706865.
  • Zhang W-Y, Guo Y-J, Han W-X, Yang M-Q, Wen L-P, Wang K-Y, Jiang P. Curcumin relieves depressive-like behaviors via inhibition of the NLRP3 inflammasome and kynurenine pathway in rats suffering from chronic unpredictable mild stress. Int Immunopharmacol. 2019;67:138–144. doi:10.1016/j.intimp.2018.12.012.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.